Cwm, LLC Forte Biosciences, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Sep 15, 2021	BUY	$6.92 - $43.2 $456 - $2,851	66 New	66 $2,000
Q1 2020 Apr 28, 2020	SELL	$6.92 - $43.2 $456 - $2,851	-66 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$6.64 - $11.23 $438 - $741	66 New	66 $2,000
Q4 2019 Jan 27, 2020	SELL	$6.64 - $11.23 $438 - $741	-66 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$9.93 - $96.15 $655 - $6,345	66 New	66 $2,000
Q3 2019 Oct 22, 2019	SELL	$9.93 - $96.15 $655 - $6,345	-66 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$63.3 - $165.0 $4,177 - $10,890	66 New	66 $2,000
Q2 2019 Jul 31, 2019	SELL	$63.3 - $165.0 $4,177 - $10,890	-66 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$127.5 - $174.6 $8,415 - $11,523	66 New	66 $0

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.66 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $426M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.